Cargando…
Novel Abs targeting the N‐terminus of fibroblast growth factor 19 inhibit hepatocellular carcinoma growth without bile‐acid‐related side‐effects
Hepatocellular carcinoma (HCC) is a common and particularly fatal form of cancer for which very few drugs are effective. The fibroblast growth factor 19 (FGF19) has been viewed as a driver of HCC development and a potential Ab target for developing novel HCC therapy. However, a previously developed...
Autores principales: | Liu, Huisi, Zheng, Sanduo, Hou, Xinfeng, Liu, Ximing, Du, Kaixin, Lv, Xueyuan, Li, Yulu, Yang, Fang, Li, Wenhui, Sui, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226213/ https://www.ncbi.nlm.nih.gov/pubmed/32061104 http://dx.doi.org/10.1111/cas.14353 |
Ejemplares similares
-
A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic efficacy and safety
por: Li, Yulu, et al.
Publicado: (2023) -
A potent human neutralizing antibody Fc-dependently reduces established HBV infections
por: Li, Dan, et al.
Publicado: (2017) -
The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance
por: Yan, Xinfeng, et al.
Publicado: (2017) -
The effect of platelet derived growth factor-AB on periodontal ligament fibroblasts: An in vitro study
por: Manoranjan, S. J., et al.
Publicado: (2012) -
Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids
por: Zhang, Justine H., et al.
Publicado: (2013)